Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Journal of Medical Genetics
|
August 16, 2003
Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers
A Morrone, C Cavicchi, T Bardelli, et al.
The British Journal of Dermatology
|
June 19, 2007
Fabry disease and the skin: data from FOS, the Fabry outcome survey
C H Orteu, T Jansen, O Lidove, et al.
Clinical Genetics
|
May 1, 2008
Enzyme replacement therapy with agalsidase alfa in a cohort of Italian patients with Anderson-Fabry disease: testing the effects with the Mainz Severity Score Index
R Parini, M Rigoldi, F Santus, et al.
Molecular Genetics and Metabolism
|
May 2, 2017
The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
P Harmatz, C J Hendriksz, C Lampe, et al.
The British Journal of Dermatology
|
March 29, 2012
Angiokeratoma: decision-making aid for the diagnosis of Fabry disease
A Zampetti, C H Orteu, D Antuzzi, et al.
Journal of Inherited Metabolic Disease
|
July 15, 2000
Carbohydrate-deficient glycoprotein syndromes: the Italian experience
M Di Rocco, R Barone, A Adami, et al.
Gene
|
December 17, 2011
Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohort
S Funghini, J Thusberg, M Spada, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 7, 2008
Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study
S Buechner, M Moretti, A P Burlina, et al.
Biochimica Et Biophysica Acta
|
November 28, 2009
Functional studies of new GLA gene mutations leading to conformational Fabry disease
C Filoni, A Caciotti, L Carraresi, et al.
Hormone Research in Paediatrics
|
January 10, 2014
Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1b
D Melis, R Pivonello, M Cozzolino, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Journal of Medical Genetics
|
August 16, 2003
Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers
A Morrone, C Cavicchi, T Bardelli, et al.
The British Journal of Dermatology
|
June 19, 2007
Fabry disease and the skin: data from FOS, the Fabry outcome survey
C H Orteu, T Jansen, O Lidove, et al.
Clinical Genetics
|
May 1, 2008
Enzyme replacement therapy with agalsidase alfa in a cohort of Italian patients with Anderson-Fabry disease: testing the effects with the Mainz Severity Score Index
R Parini, M Rigoldi, F Santus, et al.
Molecular Genetics and Metabolism
|
May 2, 2017
The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
P Harmatz, C J Hendriksz, C Lampe, et al.
The British Journal of Dermatology
|
March 29, 2012
Angiokeratoma: decision-making aid for the diagnosis of Fabry disease
A Zampetti, C H Orteu, D Antuzzi, et al.
Journal of Inherited Metabolic Disease
|
July 15, 2000
Carbohydrate-deficient glycoprotein syndromes: the Italian experience
M Di Rocco, R Barone, A Adami, et al.
Gene
|
December 17, 2011
Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohort
S Funghini, J Thusberg, M Spada, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 7, 2008
Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study
S Buechner, M Moretti, A P Burlina, et al.
Biochimica Et Biophysica Acta
|
November 28, 2009
Functional studies of new GLA gene mutations leading to conformational Fabry disease
C Filoni, A Caciotti, L Carraresi, et al.
Hormone Research in Paediatrics
|
January 10, 2014
Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1b
D Melis, R Pivonello, M Cozzolino, et al.
Page
of 8